Catherine Vézina

785 total citations
12 papers, 295 citations indexed

About

Catherine Vézina is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Catherine Vézina has authored 12 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Catherine Vézina's work include CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Catherine Vézina is often cited by papers focused on CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Catherine Vézina collaborates with scholars based in Canada, United Kingdom and United States. Catherine Vézina's co-authors include Scot Ebbinghaus, Lynley V. Marshall, Margaret E. Macy, Julia Glade Bender, Steven G. DuBois, Theodore W. Laetsch, Birgit Geoerger, Alberto S. Pappo, Susan L. Cohn and Scott J. Diede and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Catherine Vézina

9 papers receiving 292 citations

Peers

Catherine Vézina

ONCOL

NEURO

IMMUN

HEMAT

Yuki Arakawa Japan

Masahiro Sekimizu Japan

Michal Yalon-Oren Australia

Florence Broussais‐Guillaumot France

Lynny Yung United Kingdom

Mitsuteru Hiwatari Japan

Ricardo López Almaraz Spain

Ingrid Vášová Czechia

Carmelo Bengala Italy

Yuki Arakawa Japan

Catherine Vézina

67 ×0.4

ONCOL

63 ×0.9

NEURO

32 ×0.5

IMMUN

31 ×0.5

37 ×0.7

HEMAT

Citations per year, relative to Catherine Vézina Catherine Vézina (= 1×) peers Yuki Arakawa

Countries citing papers authored by Catherine Vézina

Since Specialization

Citations

This map shows the geographic impact of Catherine Vézina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Vézina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Vézina more than expected).

Fields of papers citing papers by Catherine Vézina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Vézina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Vézina. The network helps show where Catherine Vézina may publish in the future.

Co-authorship network of co-authors of Catherine Vézina

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Vézina. A scholar is included among the top collaborators of Catherine Vézina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Vézina. Catherine Vézina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Coltin, Hallie, Henrique Bittencourt, Uma H. Athale, et al.. (2025). Impact of obesity on outcome in children diagnosed with cancer in Canada: A report from Cancer in Young People in Canada. Cancer. 131(2). e35673–e35673.

Freyçon, Claire, Vincent‐Philippe Lavallée, David Mitchell, et al.. (2024). Pediatric acute promyelocytic leukemia and Fanconi anemia: Case report and literature review. Clinical Genetics. 106(2). 193–198.

El‐Ghar, Mohamed Abou, Roman Jednak, Sharon Abish, et al.. (2023). Case Report of Renal Calculi in a Child Receiving Imatinib for Acute Lymphoblastic Leukemia. Canadian Journal of Kidney Health and Disease. 10. 1035171049–1035171049.

Geoerger, Birgit, Hyoung Jin Kang, Michal Yalon-Oren, et al.. (2019). Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial. The Lancet Oncology. 21(1). 121–133. 208 indexed citations

Geoerger, Birgit, Hyoung Jin Kang, Michal Yalon-Oren, et al.. (2018). KEYNOTE-051: An update on the phase 2 results of pembrolizumab (pembro) in pediatric patients (pts) with advanced melanoma or a PD-L1–positive advanced, relapsed or refractory solid tumor or lymphoma.. Journal of Clinical Oncology. 36(15_suppl). 10525–10525. 12 indexed citations

Bitzan, Martin, et al.. (2018). Acquired thrombotic thrombocytopenic purpura with isolated CFHR3/1 deletion—rapid remission following complement blockade. Pediatric Nephrology. 33(8). 1437–1442. 7 indexed citations

Bonnefoy, Arnaud, Clémence Merlen, C. Demers, et al.. (2018). A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third‐generation B‐domain‐deleted recombinant factor VIII. Haemophilia. 24(2). 236–244. 4 indexed citations

Alkhunaizi, Ebba, et al.. (2017). Novel 3q27.2‐qter deletion in a patient with Diamond–Blackfan anemia and immunodeficiency: Case report and review of literature. American Journal of Medical Genetics Part A. 173(6). 1514–1520. 5 indexed citations

Geoerger, Birgit, Hyoung Jin Kang, Michal Yalon-Oren, et al.. (2017). Phase 1/2 KEYNOTE-051 study of pembrolizumab (pembro) in pediatric patients (pts) with advanced melanoma or a PD-L1⁺ advanced, relapsed, or refractory solid tumor or lymphoma.. Journal of Clinical Oncology. 35(15_suppl). 10525–10525. 13 indexed citations

10.

Vézina, Catherine, Zsuzsanna Bereczky, Ëva Katona, et al.. (2015). Alloantibody developed in a factor XIII A subunit deficient patient during substitution therapy; characterization of the antibody. Haemophilia. 22(2). 268–275. 12 indexed citations

11.

Vézina, Catherine, Manuel Carção, Claire Infante‐Rivard, et al.. (2014). Incidence and risk factors for inhibitor development in previously untreated severe haemophilia A patients born between 2005 and 2010. Haemophilia. 20(6). 771–776. 26 indexed citations

12.

Vézina, Catherine, et al.. (2012). Procedural Pediatric Sedation by Nurses: Available, Competent, and Safe. International Journal of Pediatrics. 2012. 1–5. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact